TriSalus Life Sciences, Inc. TLSI Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares)?
- TriSalus Life Sciences, Inc. (TLSI) reported common stock, shares authorized (in shares) of $400M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $400M to $400M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares)?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s common stock, shares authorized (in shares) has grown at a 134.8% compound annual growth rate (CAGR), from $30.9M to $400M.